Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1121P is a non-functional gene (pseudogene) representing a duplicated and inactive version of the gene coding for U6 small nuclear RNA. U6 snRNA plays a key role in pre-mRNA splicing as part of the spliceosome, but RNU6-1121P is not expressed to form functional snRNA and does not contribute to cellular processes. Pseudogenes like RNU6-1121P are common in vertebrate genomes where they serve as genetic remnants of evolution and do not encode active molecules or proteins[2][5][3]. Key distinctions: - U6 snRNA is critical for splicing[1][3], but RNU6-1121P is only a non-coding pseudogene copy without cellular function. - It is not a receptor, enzyme, transporter, channel, transcription factor, or any therapeutic target. - No drugs, no biomarkers, no direct relevance to human disease, and no therapeutic applications. If you are seeking information about the functional U6 snRNA, consult sources explicitly referring to the active gene, not its pseudogenes[1][3].
None (not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1121, pseudogene (RNU6-1121P).